Medication adherence: A practical measurement selection guide using case studies

Patient Education and Counseling

Volumn 100, Issue 7, 2017, Pages 1410-1414

  Zullig, Leah L ^a,b   Mendys, Phil ^c   Bosworth, Hayden B ^a,b,d  

^a DURHAM VA HEALTH CARE SYSTEM   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PFIZER INC   (United States)

^d DUKE UNIVERSITY   (United States)

Author keywords

Case studies; Measurement; Medication adherence

Indexed keywords

ACADEMIC RESEARCHER; CASE STUDY; HEALTH CARE PAYER; HEALTH CARE PERSONNEL; HUMAN; MEASUREMENT; MEDICATION COMPLIANCE; NOTE; PRIORITY JOURNAL; RELIABILITY; TREATMENT REFUSAL; VALIDITY; PRACTICE GUIDELINE;

GUIDELINES AS TOPIC; HUMANS; MEDICATION ADHERENCE;

EID: 85012886876     PISSN: 07383991     EISSN: 18735134     Source Type: Journal    
DOI: 10.1016/j.pec.2017.02.001     Document Type: Note

References (42)

1. Sabaté, E., Adherence to Long-term Therapies: Evidence for Action. 2003, World Health Organization.
2. DiMatteo, M.R., Giordani, P.J., Lepper, H.S., Croghan, T.W., Patient adherence and medical treatment outcomes: a meta-analysis. Med. Care 40:9 (2002), 794–811.
3. Wertheimer, A.I., Santella, T.M., Medication compliance research: still so far to go. J. Appl. Res., 3(3), 2003.
4. Brown, M.T., Bussell, J.K., Medication adherence: WHO cares?. Mayo Clin. Proc. 86:4 (2011), 304–314.
5. Aggarwal, B., Mosca, L., Lifestyle and psychosocial risk factors predict non-adherence to medication. Ann. Behav. Med.: Publ. Soc. Behav. Med. 40:2 (2010), 228–233.
6. Osterberg, L., OBlaschke, T., Adherence to medication. N. Engl. J. Med. 353:5 (2005), 487–497.
7. Haynes, R.B., Ackloo, E., Sahota, N., McDonald, H.P., Yao, X., Interventions for enhancing medication adherence. Cochrane Database Syst. Rev.(2), 2008, Cd000011.
8. Haynes, R.B., McDonald, H., Garg, A.X., Montague, P., Interventions for helping patients to follow prescriptions for medications. Cochrane Database Syst. Rev.(2), 2002, Cd000011.
9. Vrijens, B., De Geest, S., Hughes, D.A., Przemyslaw, K., Demonceau, J., Ruppar, T., Dobbels, F., Fargher, E., Morrison, V., Lewek, P., A new taxonomy for describing and defining adherence to medications. Br. J. Clin. Pharmacol. 73:5 (2012), 691–705.
10. Hutchins, D.S., Zeber, J.E., Roberts, C.S., Williams, A.F., Manias, E., Peterson, A.M., Initial medication adherence-review and recommendations for good practices in outcomes research: an ISPOR medication adherence and persistence special interest group report. Value Health: J. Int. Soc. Pharma. Outcomes Res. 18:5 (2015), 690–699.
11. Iglay, K., Cartier, S.E., Rosen, V.M., Zarotsky, V., Rajpathak, S.N., Radican, L., Tunceli, K., Meta-analysis of studies examining medication adherence, persistence, and discontinuation of oral antihyperglycemic agents in type 2 diabetes. Curr. Med. Res. Opin. 31:7 (2015), 1283–1296.
12. Lam, W.Y., Fresco, P., Medication adherence measures: an overview. BioMed Res. Int., 2015, 2015, 217047.
13. Conn, V.S., Ruppar, T.M., Chase, J.A., Enriquez, M., Cooper, P.S., Interventions to improve medication adherence in hypertensive patients: systematic review and meta-analysis. Curr. Hypertens. Rep., 17(12), 2015, 94.
14. Demonceau, J., Ruppar, T., Kristanto, P., Hughes, D.A., Fargher, E., Kardas, P., De Geest, S., Dobbels, F., Lewek, P., Urquhart, J., Identification and assessment of adherence-enhancing interventions in studies assessing medication adherence through electronically compiled drug dosing histories: a systematic literature review and meta-analysis. Drugs 73:6 (2013), 545–562.
15. Peterson, A.M., Takiya, L., Finley, R., Meta-analysis of trials of interventions to improve medication adherence. Am. J. Health-Syst. Pharm. 60:7 (2003), 657–665.
16. Farmer, K.C., Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice. Clin. Ther. 21:6 (1999), 1074–1090 discussion 1073.
17. Krousel-Wood, M., Holt, E., Joyce, C., Ruiz, R., Dornelles, A., Webber, L.S., Morisky, D.E., Frohlich, E.D., Re, R.N., He, J., Differences in cardiovascular disease risk when antihypertensive medication adherence is assessed by pharmacy fill versus self-report: the Cohort Study of Medication Adherence among Older Adults (CoSMO). J. Hypertens. 33:2 (2015), 412–420.
18. Nguyen, T.M., La Caze, A., Cottrell, N., What are validated self-report adherence scales really measuring? A systematic review. Br. J. Clin. Pharmacol. 77:3 (2014), 427–445.
19. Steiner, J.F., Prochazka, A.V., The assessment of refill compliance using pharmacy records: methods, validity, and applications. J. Clin. Epidemiol. 50:1 (1997), 105–116.
20. Culig, J., Leppee, M., From Morisky to Hill-bone; self-reports scales for measuring adherence to medication. Coll. Antropol. 38:1 (2014), 55–62.
21. Jimmy, B., Jose, J., Patient medication adherence: measures in daily practice. Oman. Med. J. 26:3 (2011), 155–159.
22. Lehmann, A., Aslani, P., Ahmed, R., Celio, J., Gauchet, A., Bedouch, P., Bugnon, O., Allenet, B., Schneider, M.P., Assessing medication adherence: options to consider. Int. J. Clin. Pharm. 36:1 (2014), 55–69.
23. Shi, L., Liu, J., Fonseca, V., Walker, P., Kalsekar, A., Pawaskar, M., Correlation between adherence rates measured by MEMS and self-reported questionnaires: a meta-analysis. Health Qual. Life Outcomes, 8, 2010, 99.
24. Stirratt, M.J., Dunbar-Jacob, J., Crane, H.M., Simoni, J.M., Czajkowski, S., Hilliard, M.E., Aikens, J.E., Hunter, C.M., Velligan, D.I., Huntley, K., et al. Self-report measures of medication adherence behavior: recommendations on optimal use. Transl. Behav. Med. 5:4 (2015), 470–482.
25. Bergsbaken, J.J., Eickhoff, J.C., Buss, B.A., Mably, M.S., Kolesar, J.M., Assessment of adherence with oral anticancer agents in oncology clinical trials: a systematic review. J. Oncol. Pharm. Pract. 22:1 (2016), 105–113.
26. Bourmaud, A., Henin, E., Tinquaut, F., Regnier, V., Hamant, C., Colomban, O., You, B., Ranchon, F., Guitton, J., Girard, P., et al. Adherence to oral anticancer chemotherapy: what influences patients' over or non-adherence? Analysis of the OCTO study through quantitative-qualitative methods. BMC Res. Notes, 8, 2015, 291.
27. Simons, S., Ringsdorf, S., Braun, M., Mey, U.J., Schwindt, P.F., Ko, Y.D., Schmidt-Wolf, I., Kuhn, W., Jaehde, U., Enhancing adherence to capecitabine chemotherapy by means of multidisciplinary pharmaceutical care. Support. Care Cancer 19:7 (2011), 1009–1018.
28. Waterhouse, D.M., Calzone, K.A., Mele, C., Brenner, D.E., Adherence to oral tamoxifen: a comparison of patient self-report, pill counts, and microelectronic monitoring. J. Clin. Oncol. 11:6 (1993), 1189–1197.
29. Deschamps, A.E., De Geest, S., Vandamme, A.M., Bobbaers, H., Peetermans, W.E., Van Wijngaerden, E., Diagnostic value of different adherence measures using electronic monitoring and virologic failure as reference standards. Aids Patient Care STDS 22:9 (2008), 735–743.
30. Zullig, L.L., Peppercorn, J.M., Schrag, D., Taylor Jr, D.H., Lu, Y., Samsa, G., Abernethy, A.P., Zafar, S.Y., Financial distress, use of cost-coping strategies, and adherence to prescription medication among patients with cancer. J. Oncol. Pract. 9:6S (2013), 60s–63s.
31. Bestvina, C.M., Zullig, L.L., Rushing, C., Chino, F., Samsa, G.P., Altomare, I., Tulsky, J., Ubel, P., Schrag, D., Nicolla, J., Patient-oncologist cost communication, financial distress, and medication adherence. J. Oncol. Pract. 10:3 (2014), 162–167.
32. Nau, D.P., Proportion of Days Covered (PDC) as a Preferred Method of Measuring Medication Adherence. 2012, Pharmacy Quality Alliance, Springfield, VA.
33. Sattler, E.L., Lee, J.S., Perri, M. 3rd, Medication (re)fill adherence measures derived from pharmacy claims data in older Americans: a review of the literature. Drugs Aging 30:6 (2013), 383–399.
34. Enhancements to Medicare Part D Patient Safety Reports and Website. https://www.cms.gov/Medicare/Prescription-Drug-Coverage/PrescriptionDrugCovContra/downloads/2010PtSafetyReportEnhan_memo_093010.pdf.
35. Krousel-Wood, M., Islam, T., Webber, L.S., Re, R., Morisky, D.E., Muntner, P., New medication adherence scale versus pharmacy fill rates in hypertensive seniors. Am. J. Manag. Care 15:1 (2009), 59–66.
36. Clifford, S., Perez-Nieves, M., Skalicky, A.M., Reaney, M., Coyne, K.S., A systematic literature review of methodologies used to assess medication adherence in patients with diabetes. Curr. Med. Res. Opin. 30:6 (2014), 1071–1085.
37. Garfield, S., Clifford, S., Eliasson, L., Barber, N., Willson, A., Suitability of measures of self-reported medication adherence for routine clinical use: a systematic review. BMC Med. Res. Methodol., 11, 2011, 149.
38. Kim, M.T., Hill, M.N., Bone, L.R., Levine, D.M., Development and testing of the hill-bone compliance to high blood pressure therapy scale. Prog. Cardiovasc. Nurs. 15:3 (2000), 90–96.
39. Song, Y., Han, H.R., Song, H.J., Nam, S., Nguyen, T., Kim, M.T., Psychometric evaluation of hill-bone medication adherence subscale. Asian Nurs. Res. 5:3 (2011), 183–188.
40. McKethan, A., Benner, J., Brookhart, A., Seizing the opportunity to improve medication adherence. HealthAffairs Blog, Vol. 2016, 2012.
41. Granger, B.B., Bosworth, H.B., Medication adherence: emerging use of technology. Curr. Opin. Cardiol. 26:4 (2011), 279–287.
42. Zullig, L., Shaw, R., Bosworth, H., Applying technology to medication management and adherence. Behavioral Health Care and Technology: Using Science-based Innovations to Transform Practice, 2014, Oxford University Press, Oxford.